Phio Pharmaceuticals Corp. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Phio Pharmaceuticals Corp. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2011 to Q2 2024.
  • Phio Pharmaceuticals Corp. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$1.85M, a 27.6% increase year-over-year.
  • Phio Pharmaceuticals Corp. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$8.68M, a 30.4% increase year-over-year.
  • Phio Pharmaceuticals Corp. annual Net Income (Loss) Attributable to Parent for 2023 was -$10.8M, a 5.7% increase from 2022.
  • Phio Pharmaceuticals Corp. annual Net Income (Loss) Attributable to Parent for 2022 was -$11.5M, a 13.6% increase from 2021.
  • Phio Pharmaceuticals Corp. annual Net Income (Loss) Attributable to Parent for 2021 was -$13.3M, a 51.1% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$8.68M -$1.85M +$703K +27.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$9.38M -$2.15M +$1.45M +40.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-14
Q4 2023 -$10.8M -$1.9M +$836K +30.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$11.7M -$2.78M +$796K +22.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$12.5M -$2.55M -$18K -0.71% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$12.4M -$3.6M -$960K -36.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-14
Q4 2022 -$11.5M -$2.73M +$720K +20.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$12.2M -$3.58M +$166K +4.44% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$12.4M -$2.53M +$156K +5.81% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$12.5M -$2.64M +$765K +22.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$13.3M -$3.45M -$989K -40.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 -$12.3M -$3.74M -$1.43M -62.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$10.9M -$2.69M -$1.02M -60.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$9.85M -$3.41M -$1.06M -44.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$8.79M -$2.46M +$198K +7.44% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-22
Q3 2020 -$8.99M -$2.31M -$215K -10.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$8.78M -$1.67M +$363K +17.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 -$9.14M -$2.35M -$232K -10.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
Q4 2019 -$8.91M -$2.66M -$933K -54% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q3 2019 -$7.98M -$2.09M -$601K -40.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$7.37M -$2.04M -$134K -7.05% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-10
Q1 2019 -$7.24M -$2.12M +$120K +5.36% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-10
Q4 2018 -$7.36M -$1.73M +$275K +13.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-26
Q3 2018 -$7.64M -$1.49M +$983K +39.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$8.62M -$1.9M +$613K +24.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-12
Q1 2018 -$9.23M -$2.24M +$3.22M +59% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-12
Q4 2017 -$12.5M -$2M +$337K +14.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-27
Q3 2017 -$12.8M -$2.48M -$264K -11.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$12.5M -$2.51M -$302K -13.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$12.2M -$5.46M -$3.23M -145% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$8.99M -$2.34M +$277K +10.6% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-26
Q3 2016 -$9.27M -$2.21M +$284K +11.4% Jul 1, 2016 Sep 30, 2016 10-Q/A 2018-03-26
Q2 2016 -$9.56M -$2.21M -$46K -2.12% Apr 1, 2016 Jun 30, 2016 10-Q/A 2018-03-26
Q1 2016 -$9.51M -$2.23M +$714K +24.2% Jan 1, 2016 Mar 31, 2016 10-Q/A 2018-03-26
Q4 2015 -$10.2M -$2.62M -$312K -13.5% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-30
Q3 2015 -$9.91M -$2.5M -$290K -13.1% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$9.62M -$2.17M -$160K -7.98% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$9.46M -$2.95M -$661K -28.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 -$8.8M -$2.3M +$204K +8.13% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$9M -$2.21M -$147K -7.14% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$8.86M -$2.01M -$45K -2.3% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 -$8.81M -$2.28M +$12.1M +84.1% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 -$20.9M -$2.51M -$797K -46.6% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-30
Q3 2013 -$20.1M -$2.06M -$415K -25.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$19.7M -$1.96M +$5.64M +74.2% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$25.4M -$14.4M -$12.5M -648% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$12.9M -$1.71M Oct 1, 2012 Dec 31, 2012 10-K 2014-03-28
Q3 2012 -$1.64M +$399K +19.5% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$7.6M -$5.72M -304% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$1.93M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q3 2011 -$2.04M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 -$1.88M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.